A male-specific increase in the HLA-DRB4 (DR53) frequency in high-risk and relapsed childhood ALL

Leukemia Research

Volumn 26, Issue 7, 2002, Pages 651-656

  Dorak, M Tevfik ^a   Oguz, Fatma S ^b   Yalman, Nevin ^c   Diler, A Sarper ^b   Kalayoglu, Sevgi ^c   Anak, Sema ^c   Sargin, Deniz ^c   Carin, Mahmut ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acute lymphoblastic leukemia; Gender effect; Genetic susceptibility; HLA DR

Indexed keywords

HLA DR ANTIGEN; HLA DR4 ANTIGEN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; HIGH RISK POPULATION; HLA SYSTEM; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE;

ADULT; ANTIGENS, NEOPLASM; CHILD; FEMALE; GENE FREQUENCY; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, LYMPHOCYTIC, ACUTE, L2; MALE; RECURRENCE; RETROSPECTIVE STUDIES; RISK; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 0036236094     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00189-8     Document Type: Article

References (57)

1. Genetic basis of susceptibility to viral leukaemogenesis
2. Genetic control of T cell responsiveness to the Friend murine leukemia virus envelope antigen. Identification of class II loci of the H-2 as immune response genes
3. Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T but not late B cell lymphomas
4. Genetic control of murine viral leukemogenesis [review]
5. Recent studies on the role of the immune response in resistance to virus-induced leukemias and lymphomas [review]
6. Tumour susceptibility in mice in relation to H-2 haplotype [review]
7. Genetics of tumor susceptibility in the mouse: MHC and non-MHC genes [review]
8. HLA-A, B and DR antigens in chronic lymphocytic leukaemia
9. Definition of a possible genetic basis for susceptibility to acute myelogenous leukemia associated with the presence of a polymorphic Ia epitope
10. Human major histocompatibility complex contains several leukemia susceptibility genes
11. Nature of HLA-associated predisposition to childhood acute lymphoblastic leukemia
12. Influence of the major histocompatibility complex on age at onset of chronic lymphoid leukaemia
13. Unravelling an HLA-DR association in childhood acute lymphoblastic leukemia
14. Association of chronic lymphocytic leukemia with specific alleles of the HLA-DR4:DR53:DQ8 haplotype in German patients
15. HLA-DRw antigens associated with acute leukemia
16. Study of the HLA system in Burkitt's lymphoma
17. HLA and testicular cancer
18. Germ cell tumours of the testicle as a model of MHC influence on human malignancy [letter]
19. HLA antigens and germ-cell tumours [letter]
20. High-resolution HLA-DRB1 and DQB1 genotyping in Japanese patients with testicular germ cell carcinoma
21. Association of HLA-DR antigens with disease severity in Japanese patients with rheumatoid arthritis
22. Association of HLA-DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a follow-up study
23. Gender and treatment outcome in childhood lymphoblastic leukaemia: Report from the MRC UKALL trials
24. Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: Differences in outcome are poorly explained by the most significant prognostic variables. Fralle group. French Acute Lymphoblastic Leukaemia study group
25. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: Results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia
26. Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party
27. The relevance of HLA in survival following bone marrow transplantation
28. Treatment of adult ALL according to protocols of the German Multicenter Study Group for adult ALL (GMALL)
29. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 h: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
30. The C282Y mutation of HFE is another male-specific risk factor for childhood ALL [letter]
31. Genetic and viral factors influencing the development of spontaneous leukemia in AKR mice
32. Contrasting effects from a single major histocompatibility complex class II molecule (H-2E) in recovery from Friend virus leukemia
33. A male-female differential in tumour incidence
34. Sex differences in susceptibility to infections
35. Immunological bases for superior survival of females
36. The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex
37. Extensive deletions and insertions in different MHC supratypes detected by pulsed field gel electrophoresis
38. Molecular analysis of the MHC class II region in DR4, DR7, and DR9 haplotypes
39. An analysis of variation in the long-range genomic organization of the human major histocompatibility complex class II region by pulsed-field gel electrophoresis
40. Map of the human MHC [review]
41. Molecular analyses of the possible RNA-binding protein gene located in the human leukocyte antigen (HLA) - DR subregion
42. Haplotype-specific sequence encoding the protein kinase, interferon-inducible double-stranded RNA-dependent activator in the human leukocyte antigen class II region
43. The association of HLA-DR5 antigen with longer survival in childhood leukaemia
44. Genetic and technical aspects of the HLA system and its possible role in human malignancy
45. Increase of HLA-DR4 in melanoma patients from Alabama
46. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity
47. Decreased frequency of HLA-DRB1 13 alleles in French women with HPV-positive carcinoma of the cervix
48. HLA and susceptibility to cervical neoplasia
49. Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment
50. *1302 protect against chronic hepatitis B
51. Evolutionary relationship of HLA-DRB genes inferred from intron sequences
52. Presence of retroelements reveal the evolutionary history of the human DR haplotypes
53. Differential transcriptional activities of HLA-DR genes in the various haplotypes
54. Quantitative analysis of the expression of the HLA-DRB genes at the transcriptional level by competitive polymerase chain reaction
55. Certain HLA antigens are associated with specific morphologic and cytogenetic subsets of acute myeloid leukemia